Peter Thiel, a wannabe Bathory. Thiel seems to share an obsession which is common among those with an absolutely filthy amount of money – he wants to live forever and ever. Or at least, a seriously long time. The key to a very, very long life? Blood. Specifically, the blood of young people. It’s magical, a resetting of gene expression, doncha know? I’m no scientist, not even close to one, but this seems to me to be more of that age old tradition of parting a fool from his money.
Billionaire PayPal founder Peter Thiel said that he believes transfusions of blood from young people can reverse his aging process and allow him to live a vastly extended lifespan.
In an interview with Inc.com’s Jeff Bercovici, Thiel said that the practice — known as parabiosis — is the closest modern science has come to creating an anti-aging panacea.
Thiel — a hedge funder who acted as a delegate for Donald Trump and spoke at the 2016 Republican National Convention — is reportedly obsessed with defying death and extending the human lifespan. He has injected funds into startups that are experimenting with ways to forestall the body’s inevitable decline and death.
“I’m looking into parabiosis stuff,” Thiel told Bercovici, “where they [injected] the young blood into older mice and they found that had a massive rejuvenating effect. … I think there are a lot of these things that have been strangely underexplored.”
Just a thought here, but as there really is nothing new under the sun, perhaps there’s a reason this whole “blood of the young!” business is so um, strangely under explored.
Parabiosis experiments began in the 1950s with crude exercises in which rats were cut open and their circulatory systems restructured and manipulated. Recently, some companies have been advancing human trials with parabiosis. Bercovici wrote that U.S. studies in the field are currently lagging behind trials in China and Korea.
A California company called Ambrosia is conducting human trials in which healthy people aged 35 or older receive transfusions of blood plasma from people under 25. Participants pay $8,000 to take part and their health is closely monitored for the two years they receive the transfusions. Participants must live in or have the means to travel to Monterey, CA.
Ambrosia’s founder Jesse Karmazin told Bercovici that participants experience a reversal of aging systems across every major organ system. Furthermore, the results appear to be long-lasting, he said, if not permanent.
Right. Only $8,000? Gee, I’ll be right over. Interesting that they are starting with 35 years old. 35 is pretty damn young, and it would be easy enough to fool yourself into thinking you feel so much younger at that age. Limit yourself to people who are 55 and older, and we can talk.
“The effects seem to be almost permanent,” Karmazin said. “It’s almost like there’s a resetting of gene expression.”
Someone else who doesn’t understand biology, but is conducting longevity experiments. Okay.
In an interview last year, Thiel told Bercovici that our culture is “a little too biased against all these things” that purportedly prolong life. When the reporter asked Thiel if he was looking at parabiosis as a business opportunity or a personal medial decision, Thiel said the latter. The practice, he said, isn’t necessarily patentable, which compromises its potential money-making value.
However, he said, the FDA needn’t get involved or study the practice because, “it’s just blood transfusions.”
There are rumors that some wealthy individuals in Silicon Valley are doing courses of parabiosis, but Thiel said last year that he hadn’t “quite, quite, quite started yet.” A spokesman for Thiel capital said that nothing has changed since then.
Gawker reported that it received a tip claiming Thiel “spends $40,000 per quarter to get an infusion of blood from an 18-year-old based on research conducted at Stanford on extending the lives of mice.”
Goodness. I’m quite, quite, quite unimpressed. Via Raw Story.